drugset / Trial / NCT02578797
A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether daily treatment with apalutamide affects the ventricular repolarization in participants with Castration-Resistant Prostate Cancer (CRPC)
Timeline
- Start
- 2015-12-18
- Primary completion
- 2016-09-20
- Completion
- 2022-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apalutamide | Small molecule | 240 mg | Oral |